메뉴 건너뛰기




Volumn 90, Issue 7, 2010, Pages 804-805

Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CALCITRIOL; FERINJECT; INSULIN; IRON CARBOXYMALTOSE; MYCOPHENOLIC ACID; PHOSPHATE; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

EID: 77958003055     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f00a18     Document Type: Letter
Times cited : (33)

References (4)
  • 1
    • 67650215157 scopus 로고    scopus 로고
    • FGF23 elevation and hypophosphatemia after intravenous iron polymaltose:A prospective study
    • Schouten BJ, Hunt PJ, Livesey JH, et al. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose:A prospective study. J Clin Endocrinol Metab 2009; 94: 2332.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 2332
    • Schouten, B.J.1    Hunt, P.J.2    Livesey, J.H.3
  • 2
    • 52949101033 scopus 로고    scopus 로고
    • Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: A randomized controlled trial
    • Seid MH, Derman RJ, Baker JB, et al. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: A randomized controlled trial. Am J Obstet Gynecol 2008; 199: 435.el.
    • (2008) Am J Obstet Gynecol , vol.199
    • Seid, M.H.1    Derman, R.J.2    Baker, J.B.3
  • 3
    • 67650812523 scopus 로고    scopus 로고
    • Intravenous versus oral iron supplementation for correction of post-transplant anemia in renal transplant patients
    • Mudge DW, S, MTan Kiles R, Johnson DW, et al. Intravenous versus oral iron supplementation for correction of post-transplant anemia in renal transplant patients. BMC Nephrol 2009; 10: 14.
    • (2009) BMC Nephrol , vol.10 , pp. 14
    • Mudge, D.W.1    Tan, S.M.2    Kiles, R.3    Johnson, D.W.4
  • 4
    • 64549090727 scopus 로고    scopus 로고
    • Safety and tolerability of ferric carboxymal-tose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients
    • Grimmelt AC, Cohen CD, Fehr T, et al. Safety and tolerability of ferric carboxymal-tose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients. Clin Nephrol 2009; 71: 125.
    • (2009) Clin Nephrol , vol.71 , pp. 125
    • Grimmelt, A.C.1    Cohen, C.D.2    Fehr, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.